Abstract
Chronic kidney disease (CKD) is now a recognized global public health problem. It is highly prevalent and strongly associated with hypertension and cardiovascular disease (CVD); far more patients with a glomerular filtration rate below 60 ml min−1 per 1.73 m2 will die from cardiovascular causes than progress to end-stage renal disease. A better understanding of the complex mechanisms underlying the development of CVD among CKD patients is required if we are to begin devising therapy to prevent or reverse this process. Observational studies of CVD in CKD are difficult to interpret because renal impairment is almost always accompanied by confounding factors. These include the underlying disease process itself (for example, diabetes mellitus and systemic vasculitis) and the complications of CKD, such as hypertension, anaemia and inflammation. Kidney donors provide an ideal opportunity to study healthy subjects without manifest vascular disease who experience an acute change from having normal to modestly impaired renal function at the time of uninephrectomy. Prospectively examining the cardiovascular consequences of uninephrectomy using donors as a model of CKD may provide useful insight into the pathophysiology of CVD in CKD and, therefore, into how the CVD risk associated with renal impairment might eventually be reduced.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Best PJ, Reddan DN, Berger PB, Szczech LA, McCullough PA, Califf RM . Cardiovascular disease and chronic kidney disease: insights and an update. Am Heart J 2004; 148: 230–242.
Martensson J, Groth S, Rehling M, Gref M . Chromium-51-EDTA clearance in adults with a single-plasma sample. J Nucl Med 1998; 39: 2131–2137.
National Kidney Federation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1–S266.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.
Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS . Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1–12.
Schiffrin EL, Lipman ML, Mann JF . Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85–97.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY . Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296–1305.
Kurth T, de Jong PE, Cook NR, Buring JE, Ridker PM . Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. Bmj 2009; 338: b2392.
Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V . Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. Bmj 2010; 341: c4986.
Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073–2081.
Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R . The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J 2007; 28: 478–483.
McCullough PA, Jurkovitz CT, Pergola PE, McGill JB, Brown WW, Collins AJ et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med 2007; 167: 1122–1129.
Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A, Levin N et al. The burden of kidney disease: improving global outcomes. Kidney Int 2004; 66: 1310–1314.
Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, Scharling H et al. Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004; 110: 32–35.
Arnlov J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005; 112: 969–975.
Jafar TH, Stark PC, Schmid CH, Landa M, Maschio G, de Jong PE et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003; 139: 244–252.
Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM . Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85–F93.
Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, Voors AA et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004; 110: 2809–2816.
UK Transplant Data. Accessed December 2010, at www.uktransplant.org.uk.
British Transplantation Society and The Renal Association. United Kingdom Guidelines for Living Donor Kidney Transplantation. 2nd edn. British Transplantation Society and The Renal Association, 2005.
Baltzan MA, Ahmed S, Baltzan RB, Marshall RP, Thoma EL, Nicol MF . Variations in living donor graft rates by dialysis clinic: effect on outcome and cost of chronic renal failure therapy. Clin Nephrol 1997; 47: 351–355.
Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235–242.
Chin EH, Hazzan D, Edye M, Wisnivesky JP, Herron DM, Ames SA et al. The first decade of a laparoscopic donor nephrectomy program: effect of surgeon and institution experience with 512 cases from 1996 to 2006. J Am Coll Surg 2009; 209: 106–113.
Meier-Kriesche HU, Kaplan B . Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377–1381.
Terasaki PI, Cecka JM, Gjertson DW, Takemoto S . High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333–336.
Knoll G . Trends in kidney transplantation over the past decade. Drugs 2008; 68 (Suppl 1): 3–10.
Bia MJ, Ramos EL, Danovitch GM, Gaston RS, Harmon WE, Leichtman AB et al. Evaluation of living renal donors. The current practice of US transplant centers. Transplantation 1995; 60: 322–327.
Krohn AG, Ogden DA, Holmes JH . Renal function in 29 healthy adults before and after nephrectomy. JAMA 1966; 196: 322–324.
Anderson RG, Bueschen AJ, Lloyd LK, Dubovsky EV, Burns JR . Short-term and long-term changes in renal function after donor nephrectomy. J Urol 1991; 145: 11–13.
Saran R, Marshall SM, Madsen R, Keavey P, Tapson JS . Long-term follow-up of kidney donors: a longitudinal study. Nephrol Dial Transplant 1997; 12: 1615–1621.
Garg AX, Muirhead N, Knoll G, Yang RC, Prasad GV, Thiessen-Philbrook H et al. Proteinuria and reduced kidney function in living kidney donors: a systematic review, meta-analysis, and meta-regression. Kidney Int 2006; 70: 1801–1810.
Barri YM, Parker III T, Daoud Y, Glassock RJ . Definition of chronic kidney disease after uninephrectomy in living donors: what are the implications? Transplantation 2010; 90: 575–580.
Poggio ED, Wang X, Greene T, Van Lente F, Hall PM . Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459–466.
Tan JC, Ho B, Busque S, Blouch K, Derby G, Efron B et al. Imprecision of creatinine-based GFR estimates in uninephric kidney donors. Clin J Am Soc Nephrol 2010; 5: 497–502.
Ibrahim HN, Foley R, Tan L, Rogers T, Bailey RF, Guo H et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459–469.
Lentine KL, Schnitzler MA, Xiao H, Saab G, Salvalaggio PR, Axelrod D et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med 2010; 363: 724–732.
NICE. Clinical Guidelines CG73. Early identification and management of chronic kidney disease in adults in primary and secondary care. http://www.nice.org.uk/CG73 (accessed September 2008).
Gossmann J, Wilhelm A, Kachel HG, Jordan J, Sann U, Geiger H et al. Long-term consequences of live kidney donation follow-up in 93% of living kidney donors in a single transplant center. Am J Transplant 2005; 5: 2417–2424.
Hakim RM, Goldszer RC, Brenner BM . Hypertension and proteinuria: long-term sequelae of uninephrectomy in humans. Kidney Int 1984; 25: 930–936.
Chavers BM, Michael AF, Weiland D, Najarian JS, Mauer SM . Urinary albumin excretion in renal transplant donors. Am J Surg 1985; 149: 343–346.
Kasiske BL, Ma JZ, Louis TA, Swan SK . Long-term effects of reduced renal mass in humans. Kidney Int 1995; 48: 814–819.
Boudville N, Prasad GV, Knoll G, Muirhead N, Thiessen-Philbrook H, Yang RC et al. Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med 2006; 145: 185–196.
Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H et al. One- and five-year follow-ups on blood pressure and renal function in kidney donors. Transpl Int 2010; 24: 74–77.
Garg AX, Prasad GV, Thiessen-Philbrook HR, Ping L, Melo M, Gibney EM et al. Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation 2008; 86: 399–406.
Anderson CF, Velosa JA, Frohnert PP, Torres VE, Offord KP, Vogel JP et al. The risks of unilateral nephrectomy: status of kidney donors 10–20 years postoperatively. Mayo Clin Proc 1985; 60: 367–374.
Rizvi SA, Naqvi SA, Jawad F, Ahmed E, Asghar A, Zafar MN et al. Living kidney donor follow-up in a dedicated clinic. Transplantation 2005; 79: 1247–1251.
Nogueira JM, Weir MR, Jacobs S, Haririan A, Breault D, Klassen D et al. A study of renal outcomes in African American living kidney donors. Transplantation 2009; 88: 1371–1376.
Storsley LJ, Young A, Rush DN, Nickerson PW, Ho J, Suon V et al. Long-term medical outcomes among Aboriginal living kidney donors. Transplantation 2010; 90: 401–406.
Sui Y, Zhao HL, Ma RC, Ho CS, Kong AP, Lai FM et al. Pancreatic islet beta-cell deficit and glucose intolerance in rats with uninephrectomy. Cell Mol Life Sci 2007; 64: 3119–3128.
Martin FL, Huntley BK, Korinek J, Harders GE, Oehler E, Chen HH et al. New insights into the kidney-heart connection: mild renal insufficiency induces cardiac fibrosis and diastolic dysfunction followed by late systolic impairment. Circulation 2008; 118: S334–S335.
Prasad GV, Lipszyc D, Huang M, Nash MM, Rapi L . A prospective observational study of changes in renal function and cardiovascular risk following living kidney donation. Transplantation 2008; 86: 1315–1318.
Ibrahim HN, Kukla A, Cordner G, Bailey R, Gillingham K, Matas AJ . Diabetes after kidney donation. Am J Transplant 2010; 10: 331–337.
Bahous SA, Stephan A, Blacher J, Safar ME . Aortic stiffness, living donors, and renal transplantation. Hypertension 2006; 47: 216–221.
Abhayaratna WP, Yew SC, Talaulikar G . Effect of reduced renal function after voluntary kidney donation on cardiac structure and function and arterial stiffness. Circulation 2010; 122: A20745.
Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–2605.
Chue CD, Townend JN, Steeds RP, Ferro CJ . Arterial stiffness in chronic kidney disease: causes and consequences. Heart 2010; 96: 817–823.
Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tyden G, Groth CG . Kidney donors live longer. Transplantation 1997; 64: 976–978.
Segev DL, Muzaale AD, Caffo BS, Mehta SH, Singer AL, Taranto SE et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 2010; 303: 959–966.
Lindeman RD, Tobin J, Shock NW . Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 23: 278–285.
Acknowledgements
Dr WEM is supported by a British Heart Foundation Clinical Research Training Fellowship Grant.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Moody, W., Chue, C., Inston, N. et al. Understanding the effects of chronic kidney disease on cardiovascular risk: are there lessons to be learnt from healthy kidney donors?. J Hum Hypertens 26, 141–148 (2012). https://doi.org/10.1038/jhh.2011.46
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2011.46
Keywords
This article is cited by
-
Trends, Outcomes, and Evaluation of the Older Living Kidney Donor
Current Transplantation Reports (2024)
-
A therapeutic target for CKD: activin A facilitates TGFβ1 profibrotic signaling
Cellular & Molecular Biology Letters (2023)
-
Renal and cardiac assessment of living kidney donor candidates
Nature Reviews Nephrology (2017)